OR WAIT null SECS
December 18, 2024
Video
In this video, Steven Fein, MD, discusses updates and topics of note from the American Society of Hematology annual meeting.
December 08, 2024
Article
Yale study at ASH 2024 finds screening adult women for iron deficiency with a ferritin threshold of 25 µg/L is cost-effective.
December 06, 2024
Topline results from APPULSE-PNH show the positive efficacy and safety of twice-daily oral iptacopan in adults with PNH switched from anti-C5 therapies.
December 04, 2024
Dexamethasone treatment was linked to worse clinical outcomes in patients with sickle cell disease hospitalized for COVID-19.
December 03, 2024
Anemia in heart failure with preserved ejection fraction was linked to right ventricular dysfunction in an analysis of more than 1000 patients in China.
November 30, 2024
Insufficient ferric carboxymaltose dosing and timing fail to significantly improve hemoglobin levels, suggesting gaps in perioperative anemia management.
October 25, 2024
On October 25, 2024, Kind Pharmaceutical announced receipt of FDA Orphan Drug Designation for AND017 in the treatment of sickle cell disease.
October 14, 2024
Anemia could be a reliable sign of all-cause mortality in patients with heart failure.
A systematic review found cognitive impairment a defining characteristic of SCA, with a notable impact on individuals of all ages.
October 08, 2024
Education and employment, social and emotional functioning, and healthcare access are notable factors influencing pain in sickle cell disease.
